IL6 and depressive symptom measurement: From the increased levels of proinflammatory cytokines (81, 82), such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), measured in individuals diagnosed with depression, to the PET scan visualization of neuroinflammation in individuals experiencing depressive episodes (83–85).